(Post-pandemic Era)-Global Cardiac Pacing Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
- Report Code : XYZ2438777
- Published On: Apr, 2021
- Category : Semiconductor & Electronics
- Pages : 114
-
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Research published a report for global Cardiac Pacing market in this environment.
In terms of revenue, this research report indicated that the global Cardiac Pacing market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Cardiac Pacing industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Medtronic aims at producing XX K Units Cardiac Pacing in 2020, with XX % production to take place in global market, St. Jude Medical (Abbott) accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Cardiac Pacing Market Include by
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Cardiac Pacing Market
Medtronic
St. Jude Medical (Abbott)
Boston Scientific
Biotronik
LivaNova (Sorin)
Medico
IMZ
Pacetronix
Qinming Medical
Cardioelectronica
CCC
Major Type of Cardiac Pacing Covered in Research report:
Pacemaker
ICD
BI-V ICD
Application Segments Covered in Research Market
Bradycardia
Tachycardia
Heart Failure
Other
For any other requirements, please feel free to contact us and we will provide you customized report.
-
With tables and figures helping analyze worldwide (Post pandemic Era) Global Cardiac Pacing market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Global Cardiac Pacing Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope1.1 Product Details and Introduction
1.1.1 Pacemaker -Product Introduction and Major Manufacturers
1.1.2 ICD -Product Introduction and Major Manufacturers
1.1.3 BI-V ICD -Product Introduction and Major Manufacturers1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Cardiac Pacing Market Assessment, by Segmentation2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis3.1 China Cardiac Pacing Market
3.1.1 Top Companies leading Cardiac Pacing Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Cardiac Pacing Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)3.2 EU Cardiac Pacing Market
3.2.1 Top Companies leading Cardiac Pacing Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Cardiac Pacing Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)3.3 USA Cardiac Pacing Market
3.3.1 Top Companies leading Cardiac Pacing Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Cardiac Pacing Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)3.4 Japan Cardiac Pacing Market
3.4.1 Top Companies leading Cardiac Pacing Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Cardiac Pacing Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)3.5 India Cardiac Pacing Market
3.5.1 Top Companies leading Cardiac Pacing Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Cardiac Pacing Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)3.6 Southeast Asia Cardiac Pacing Market
3.6.1 Top Companies leading Cardiac Pacing Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Cardiac Pacing Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Cardiac Pacing Market
3.7.1 Top Companies leading Cardiac Pacing Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Cardiac Pacing Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)4.1 Cardiac Pacing Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream4.2 COVID-19 Impact on Cardiac Pacing Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)5.1 Global Cardiac Pacing Sales and Growth Rate (2021-2027)
5.2 Global Cardiac Pacing Sales Value and Growth Rate (2021-2027)
6 Cardiac Pacing Competitive Analysis6.1 Medtronic
6.1.1 Medtronic Company Profiles
6.1.2 Medtronic Product Introduction
6.1.3 Medtronic Cardiac Pacing Production, Revenue (2016-2021)
6.1.4 SWOT Analysis6.2 St. Jude Medical (Abbott)
6.2.1 St. Jude Medical (Abbott) Company Profiles
6.2.2 St. Jude Medical (Abbott) Product Introduction
6.2.3 St. Jude Medical (Abbott) Cardiac Pacing Production, Revenue (2016-2021)
6.2.4 SWOT Analysis6.3 Boston Scientific
6.3.1 Boston Scientific Company Profiles
6.3.2 Boston Scientific Product Introduction
6.3.3 Boston Scientific Cardiac Pacing Production, Revenue (2016-2021)
6.3.4 SWOT Analysis6.4 Biotronik
6.4.1 Biotronik Company Profiles
6.4.2 Biotronik Product Introduction
6.4.3 Biotronik Cardiac Pacing Production, Revenue (2016-2021)
6.4.4 SWOT Analysis6.5 LivaNova (Sorin)
6.5.1 LivaNova (Sorin) Company Profiles
6.5.2 LivaNova (Sorin) Product Introduction
6.5.3 LivaNova (Sorin) Cardiac Pacing Production, Revenue (2016-2021)
6.5.4 SWOT Analysis6.6 Medico
6.6.1 Medico Company Profiles
6.6.2 Medico Product Introduction
6.6.3 Medico Cardiac Pacing Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 IMZ
6.7.1 IMZ Company Profiles
6.7.2 IMZ Product Introduction
6.7.3 IMZ Cardiac Pacing Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 Pacetronix
6.8.1 Pacetronix Company Profiles
6.8.2 Pacetronix Product Introduction
6.8.3 Pacetronix Cardiac Pacing Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 Qinming Medical
6.9.1 Qinming Medical Company Profiles
6.9.2 Qinming Medical Product Introduction
6.9.3 Qinming Medical Cardiac Pacing Production, Revenue (2016-2021)
6.9.4 SWOT Analysis6.10 Cardioelectronica
6.10.1 Cardioelectronica Company Profiles
6.10.2 Cardioelectronica Product Introduction
6.10.3 Cardioelectronica Cardiac Pacing Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
6.11 CCC
7 Conclusion
-
The (Post pandemic Era) Global Cardiac Pacing Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
New players are entering the (Post pandemic Era) Global Cardiac Pacing Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.
Depending upon the type of applications, the (Post pandemic Era) Global Cardiac Pacing Market has been segmented into
From 2024 to 2029, the (Post pandemic Era) Global Cardiac Pacing Market is expected to grow at a compound annual growth rate of YY%, reaching a value of USD XXX Million.
Yes, the add-on segmentation is available in the premium customised version of the (Post pandemic Era) Global Cardiac Pacing Market report for a more in-depth analysis. It aids in the calculation of refined and precise market values.
The (Post pandemic Era) Global Cardiac Pacing Market is expected to reach a considerable market valuation.